| Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ... Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003 | 250 | 2003 |
| Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies D Vezzosi, A Bennet, P Rochaix, F Courbon, J Selves, B Pradere, ... European Journal of Endocrinology 152 (5), 757-767, 2005 | 212 | 2005 |
| The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer JA Christian, M Partridge, E Nioutsikou, G Cook, HA McNair, B Cronin, ... Radiotherapy and oncology 77 (3), 271-277, 2005 | 148 | 2005 |
| Indium-111–pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors A Asnacios, F Courbon, P Rochaix, E Bauvin, V Cances-Lauwers, ... Journal of Clinical Oncology 26 (6), 963-970, 2008 | 134 | 2008 |
| Digestive neuroendocrine neoplasms (NEN): French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR … L De Mestier, C Lepage, E Baudin, R Coriat, F Courbon, A Couvelard, ... Digestive and Liver Disease 52 (5), 473-492, 2020 | 133 | 2020 |
| Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study J Strosberg, PL Kunz, A Hendifar, J Yao, D Bushnell, MH Kulke, RP Baum, ... European journal of nuclear medicine and molecular imaging 47, 2372-2382, 2020 | 100 | 2020 |
| Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study) P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ... Journal of Nuclear Medicine 58 (7), 1045-1053, 2017 | 97 | 2017 |
| Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art L de Mestier, C Dromain, G d'Assignies, JY Scoazec, N Lassau, R Lebtahi, ... Endocrine-related cancer 21 (3), R105-R120, 2014 | 90 | 2014 |
| Sunitinib in patients with refractory advanced thyroid cancer: the THYSU phase II trial A Ravaud, C De la Fouchardière, F Courbon, J Asselineau, M Klein, ... Journal of Clinical Oncology 26 (15_suppl), 6058-6058, 2008 | 89 | 2008 |
| Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma F Thomas, P Rochaix, A Benlyazid, J Sarini, M Rives, JL Lefebvre, ... Clinical Cancer Research 13 (23), 7086-7092, 2007 | 84 | 2007 |
| Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP … A Di Giannatale, N Dias-Gastellier, A Devos, K Mc Hugh, A Boubaker, ... European journal of cancer 50 (1), 170-177, 2014 | 77 | 2014 |
| Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands P de Medina, MR Paillasse, G Ségala, F Khallouki, S Brillouet, F Dalenc, ... Chemistry and physics of lipids 164 (6), 432-437, 2011 | 70 | 2011 |
| Short‐and long‐term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism D Vezzosi, A Bennet, F Courbon, P Caron Clinical Endocrinology 68 (6), 904-911, 2008 | 70 | 2008 |
| Summary of the standards, options and recommendations for the use of positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002) P Bourguet, MP Blanc-Vincent, A Boneu, L Bosquet, B Chauffert, ... British Journal of Cancer 89 (1), S84-S91, 2003 | 58 | 2003 |
| Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3′-deoxy-3′-18F-fluorothymidine PET images in lung cancer S Thureau, P Chaumet-Riffaud, R Modzelewski, P Fernandez, ... Journal of Nuclear Medicine 54 (9), 1543-1550, 2013 | 54 | 2013 |
| Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma F Courbon, S Zerdoud, D Bastie, F Archambaud, M Hoff, N Eche, I Berry, ... Thyroid 16 (10), 1025-1031, 2006 | 52 | 2006 |
| Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume … H Metwally, F Courbon, I David, T Filleron, A Blouet, M Rives, F Izar, ... International Journal of Radiation Oncology* Biology* Physics 80 (3), 793-799, 2011 | 37 | 2011 |
| Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer A Martinez, M Voglimacci, A Lusque, A Ducassou, L Gladieff, N Dupuis, ... European journal of nuclear medicine and molecular imaging 47, 1252-1260, 2020 | 35 | 2020 |
| Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node T Wagner, N Meyer, S Zerdoud, A Julian, C Chevreau, P Payoux, ... British Journal of Dermatology 164 (6), 1235-1240, 2011 | 34 | 2011 |
| Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the … S Vergez, JP Delord, F Thomas, P Rochaix, O Caselles, T Filleron, ... Clinical Cancer Research 16 (17), 4434-4445, 2010 | 34 | 2010 |
